Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Planned sale Chief Operating Officer sold 18,612 shares at an average $69.19 ($1,287,801)
  6. 4 Planned sale Chief Medical Officer sold 5,731 shares at an average $66.38 ($380,449)
  7. 4 Planned sale Chief Financial Officer sold 6,657 shares at an average $69.23 ($460,834)
  8. 4 Planned sale Chief Medical Officer sold 7,378 shares at an average $65.88 ($486,069)
  9. 4 Planned sale Chief Financial Officer sold 353 shares at $69.06 ($24,377)
  10. 4 Planned sale Chief Financial Officer sold 11,156 shares at an average $64.51 ($719,727)
  11. 4 Open-market sale Chief Legal Officer sold 2,853 shares at $62.86 ($179,340)
  12. 4 Open-market sale Chief Commercial Officer sold 5,531 shares at $62.86 ($347,679)
  13. 4 Open-market sale Chief Medical Officer sold 3,256 shares at $62.86 ($204,672)
  14. 4 Open-market sale Chief Operating Officer sold 3,231 shares at $62.86 ($203,101)
  15. 4 Open-market sale Chief Executive Officer sold 13,264 shares at $62.86 ($833,775)
  16. 4 Grant or award Chief Legal Officer acquired 17,000 shares (grant or award)
  17. 4 Grant or award Chief Commercial Officer acquired 17,000 shares (grant or award)
  18. 4 Grant or award Chief Medical Officer acquired 17,000 shares (grant or award)
  19. 4 Grant or award Chief Operating Officer acquired 17,000 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 19,000 shares (grant or award)

Page 2 of 15 · 283 filings